Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2014 pubmed 25 citations

The impact of vitamin D on the innate immune response to uropathogenic Escherichia coli during pregnancy.

Ramos. N L NL; Sekikubo. M M; Kironde. F F; Mirembe. F F; Sääf. M M; Brauner. A A

Key Findings

  • Vitamin D (25‑OHD) and LL‑37 levels increase as pregnancy progresses, peaking in the third trimester
  • Serum from later pregnancy stages more effectively inhibits growth of uropathogenic E. coli
  • Vitamin D modulates IL‑8 responses in urothelial cells in a dose‑dependent way

Practical Outcomes

  • Keeping vitamin D levels in the optimal range may enhance innate immunity via LL‑37, potentially reducing urinary‑tract infection risk. For biohackers, regular safe vitamin D supplementation could be a simple way to boost this natural antimicrobial defense, though most data come from pregnant women and more research is needed for the general population.

Summary

During pregnancy, women's vitamin D levels naturally rise, which also boosts the antimicrobial peptide LL-37. Higher vitamin D and LL-37 make the blood better at stopping E. coli, a common cause of urinary infections. The study shows vitamin D can tweak immune signals in bladder cells, suggesting a protective effect.

Abstract

Urinary tract infections are highly common during pregnancy, and can cause serious complications for the mother and baby. Vitamin D, predominantly obtained from the sunlight, is known to have an effect on the urothelium, with immunomodulatory capacity against Escherichia coli infection. However, its influence at this site remains to be further explored. This study therefore investigated its impact during pregnancy in a population of women who have the possibility of adequate year-round sun exposure. Serum from pregnant Ugandan women (n = 32) in each trimester of pregnancy, from women after delivery (n = 29) and from never-pregnant controls (n = 25) was collected. 25-Hydroxyvitamin D (25-OHD), cathelicidin LL-37, human β-defensin 2, interleukin (IL)-8 and soluble CD14 serum concentrations were measured by chemiluminescence immunoassay or ELISA. The ability of serum to inhibit E. coli growth was tested. The immunomodulatory capacities of these serum samples and 1,25-dihydroxyvitamin D3 were investigated in urothelial cells. Increases in 25-OHD and LL-37 levels were observed as pregnancy progressed, peaking in the third trimester. Serum 25-OHD levels were higher in multigravidae than in primigravidae, and correlated positively with maternal age. IL-8 levels were lower in the third trimester than in the first trimester, increased after delivery, but remained below those of never-pregnant women. Similarly, soluble CD14 concentrations increased after delivery. As gestation advanced, serum had an increased capacity to inhibit E. coli growth. In vitro, it modulated the IL-8 response to infection in a vitamin D concentration-dependent manner. Our findings demonstrate that increasing vitamin D levels as pregnancy advances modulate the innate immune system towards a protective response to infection.

Study Information

Provider

pubmed

Year

2014

Date

2014-12-26T00:00:00.000Z

DOI

10.1016/j.cmi.2014.12.010

Citations

25

References

34